Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Bank of America Corp reported a 6.70% stake in Fulcrum Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 3, 2026
Bank of America Corp reported a 6.70% stake in Fulcrum Therapeutics, Inc., 4,468,123 shares, as a passive investor on Jun 30, 2026. Filed Aug 3, 2026 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 4,468,123
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BANK OF AMERICA CORP /DE/ | 6.70% | 4,468,123 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Bank of America Corp
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026